Evidence map›Paper›PMID 41263575›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2025

Beyond antibiotic resistance: evidence for resistance-nodulation-division (RND) efflux pumps as virulence determinants.

Corrella S Detweiler, Ilyas Alav

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Hybrid capture RNA-seq defines temporal gene expression inbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Frontiers in bioinformatics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Corrella S DetweilerDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado at Boulder, Boulder, Colorado, USA.ORCID 0000-0002-7783-0876
Ilyas AlavDepartment of Microbes, Infection, and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-7212-3371

Funding

Infection-Dependent Vulnerabilities of Gram-negative Bacterial PathogensR01AI168916 · NIAID · UNIVERSITY OF COLORADO · PI Corrella S Detweiler · 2023 to 2026
$2.2M
Using Salmonella Pathogenesis and Cell Biology as a Discovery ToolR21AI171945 · NIAID · UNIVERSITY OF COLORADO · PI DETWEILER, CORRELLA S · 2023 to 2024
$430k
NIAID NIH HHS R01 AI168916NIAID NIH HHS R21 AI171945NIH HHS R01AI168916, R21AI171945University of Birmingham
6 · The paper itself

Abstract

SUMMARYEarly in evolution, cells acquired the ability to use energy to export waste and toxic products against a concentration gradient. In Gram-negative bacteria, the resistance-nodulation-cell division (RND) superfamily of multi-subunit efflux pumps transport toxic molecules to the extracellular milieu. RND efflux pumps require cell-membrane proton motive force to export a wide range of substrates. Within the RND superfamily, Hydrophobe/Amphiphile Efflux 1 (HAE-1) family members have been studied extensively for their critical role in exporting structurally diverse antibiotics and, consequently, their contributions to multidrug resistance. However, HAE-1 RND efflux pumps are also required for pathogen survival in the mammalian host when antibiotics are absent. Here, we investigate the role of HAE-1 RND efflux pumps as virulence determinants. We analyze the genetic evidence that Gram-negative bacterial pathogens require HAE-1 RND efflux pumps to cause infection and briefly discuss the development of therapeutic and prophylactic approaches to interfere with HAE-1 RND efflux pump activity as a complement to existing antibiotics.

Indexed as

Bacterial ProteinsGram-Negative BacteriaMembrane Transport ProteinsVirulence FactorsAnimalsAnti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialGram-Negative Bacterial InfectionsHumansVirulenceAnti-Bacterial AgentsBacterial ProteinsMembrane Transport ProteinsVirulence FactorsAcrAB-TolCdrug effluxefflux pump inhibitorefflux pumpsEnterobacteriaceaegram-negative bacteriahost-pathogen interactionsRND efflux pumpvirulencevirulence determinants

Identifiers

PMID41263575
PMCPMC12713409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.